Citations

Showing 10 of 108094 citations.

Faculty Opinions recommendation of Endoscopic pyloromyotomy for the treatment of severe and refractory gastroparesis: a pilot, randomised, sham-controlled trial.
Song, Louis M. Wong Kee

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 8, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.742068413.793596364 Get It

Cardiac Resynchronization Therapy for Adult Patients With a Failing Systemic Right Ventricle: A Multicenter Study
Kharbanda, Rohit K. , Moore, Jeremy P. , Lloyd, Michael S. , Galotti, Robert, Bogers, Ad J.J.C. , Taverne, Yannick J.H.J. , Madhavan, Malini , McLeod, Christopher J. , Dubin, Anne M. , Mah, Douglas Y. , Chang, Philip M. , Kamp, Anna , Nielsen, Jens Cosedis , Aydın, Alper , Tanel, Ronn E. , Shah, Maully J. , Pilcher, Thomas , Evertz, Reinder , Tan, Reina Bianca , Czosek, Richard J. , Shivkumar, Kalyanam , Groot, Natasja M.S. de , Nielsen, Jens C , Khairy, Paul , Tan, Reina B , Czosek, Richard J , Shivkumar, Kalyanam , de Groot, Natasja M S , Dubin, Anne M , McLeod, Christopher J , Pilcher, Thomas A.

Mayo Clinic

Journal of the American Heart Association | November 8, 2022 | Volume: 11 | Issue: 22 | Pages: No page available

10.1161/jaha.121.025121 | PMID 36346046 Get It

Background The objective of this international multicenter study was to investigate both early and late outcomes of cardiac resynchronization therapy (CRT) in patients with a systemic right ventricle (SRV) and to identify predictors for congestive heart failure readmissions and mortality. Methods and Results This retrospective international multicenter study included 13 centers. The study population comprised 80 adult patients with SRV (48.9% women) with a mean age of 45±14 (range, 18–77) years at initiation of CRT. Median follow‐up time was 4.1 (25th–75th percentile, 1.3–8.3) years. Underlying congenital heart disease consisted of congenitally corrected transposition of the great arteries and dextro‐transposition of the great arteries in 63 (78.8%) and 17 (21.3%) patients, respectively. CRT resulted in significant improvement in functional class (before CRT: III, 25th–75th percentile, II–III; after CRT: II, 25th–75th percentile, II–III; P =0.005) and QRS duration (before CRT: 176±27; after CRT: 150±24 milliseconds; P =0.003) in patients with pre‐CRT ventricular pacing who underwent an upgrade to a CRT device (n=49). These improvements persisted during long‐term follow‐up with a marginal but significant increase in SRV function (before CRT; 30%, 25th–75th percentile, 25–35; after CRT: 31%, 25th–75th percentile, 21–38; P =0.049). In contrast, no beneficial change in the above‐mentioned variables was observed in patients who underwent de novo CRT (n=31). A quarter of all patients were readmitted for heart failure during follow‐up, and mortality at latest follow‐up was 21.3%. Conclusions This international experience with CRT in patients with an SRV demonstrated that CRT in selected patients with SRV dysfunction and pacing‐induced dyssynchrony yielded consistent improvement in QRS duration and New York Heart Association functional status, with a marginal increase in SRV function.
Author response: A phenotype-based forward genetic screen identifies Dnajb6 as a sick sinus syndrome gene
Yan, Jianhua , Li, Hongsong , Jiao, Kunli , Yang, Jingchun , Port, Jenna , Wang, Jun , Li, Yi‐Gang , Ding, Yonghe , Lang, Di , Bu, Haisong , Ni, Haibo , Morotti, Stefano , Le, Tai , Clark, Karl J. , Ekker, Stephen C. , Cao, Hung , Zhang, Yuji , Grandi, Eleonora , Li, Zhiqiang , Shi, Yongyong , Glukhov, Alexey V. , Xu, Xiaolei

Mayo Clinic

No container title available | November 8, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.7554/elife.77327.sa2 Get It

Faculty Opinions recommendation of Rescue treatment of postoperative nausea and vomiting: A systematic review of current clinical evidence.
Sviggum, Hans P.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 8, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.742305182.793596349 Get It

Nicotinamide Mononucleotide Prevents Cisplatin-Induced Mitochondrial Defects in Cortical Neurons Derived from Human Induced Pluripotent Stem Cells
Rashid, Mohammad Abdur , Oliveros, Alfredo , Jang, Mi‐Hyeon , Kim, Yu Shin

Mayo Clinic

Brain Plasticity | November 8, 2022 | Volume: 8 | Issue: 2 | Pages: 143-152

10.3233/bpl-220143 | PMID 36721392 Get It

Background: Chemotherapy-induced cognitive impairment (CICI) is a neurotoxic side effect of chemotherapy that has yet to have an effective treatment. Objective: Using cisplatin, a platinum-based chemotherapy together with excitatory cortical neurons derived from human induced pluripotent cells (iPSCs) to model of CICI, our recent study demonstrated that dysregulation of brain NAD + metabolism contributes to cisplatin-induced impairments in neurogenesis and cognitive function, which was prevented by administration of the NAD + precursor, nicotinamide mononucleotide (NMN). However, it remains unclear how cisplatin causes neurogenic dysfunction and the mechanism by which NMN prevents cisplatin-induced cognitive impairment. Given that mitochondrial dysfunction is thought to play a prominent role in age-related neurodegenerative disease and chemotherapy-induced neurotoxicity, we sought to explore if NMN prevents chemotherapy-related neurotoxicity by attenuating cisplatin-induced mitochondrial damage. Results: We demonstrate that cisplatin induces neuronal DNA damage, increases generation of mitochondrial reactive oxygen species (ROS) and decreases ATP production, all of which are indicative of oxidative DNA damage and mitochondrial functional defects. Ultrastructural analysis revealed that cisplatin caused loss of cristae membrane integrity and matrix swelling in human cortical neurons. Notably, pretreatment with NMN prevents cisplatin-induced defects in mitochondria of human cortical neurons. Conclusion: Our results suggest that increased mitochondrial oxidative stress and functional defects play key roles in cisplatin-induced neurotoxicity. Thus, NMN may be an effective therapeutic strategy to prevent cisplatin-induced deleterious effects on mitochondria, making this organelle a key factor in amelioration of cisplatin-induced cognitive impairments.
“Look Beyond the Skin”: A case report about chronic pruritus
Quddusi, Fatima I., Youssef, Molly J.

Mayo Clinic

SAGE Open Medical Case Reports | November 8, 2022 | Volume: 10 | Issue: No issue available | Pages: No page available

10.1177/2050313x221136008 | PMID 36388637 Get It

A healthy 23-year-old female developed generalized pruritus over a year that began on her feet and gradually progressed to involve more than 50% of her entire body surface area. Punch skin biopsies were inconclusive, whereas a two-view chest x-ray was suspicious for lymphadenopathy. A chest computed tomography scan with contrast identified an anterior mediastinal mass which was biopsied and diagnosed as a nodular sclerosis type of Hodgkin’s lymphoma. Subsequently, appropriate therapy was initiated resulting in complete resolution of the patient’s chronic itch. This case underscores the clinical significance of a comprehensive systemic evaluation in chronic pruritus of unclear etiology.
Novel Use of Intranasal Dexmedetomidine for Refractory Irritability in Pediatric Home Care
Bartoletta, Katherine M., Collura, Christopher A. , Thorvilson, Megan J.

Mayo Clinic

Journal of Palliative Medicine | November 8, 2022 | Volume: 26 | Issue: 4 | Pages: 596-598

10.1089/jpm.2022.0420 | PMID 36346281 Get It

Liver‐directed drugs for transthyretin‐mediated amyloidosis
Brannagan, Thomas H., Fontana, Marianna , Masri, Ahmad , Baker, Brenda F. , Hannan, Lisa A., Büchele, Gustavo, Viney, N., Coelho, Teresa , Nativi-Nicolau, José , Brannagan, T H , Obici, Laura , Baker, Brenda F , Gillmore, Julian D , Berk, John L. , Gillmore, Julian D. , Maurer, Matthew J. , Waddington‐Cruz, Márcia , Fontana, Marianna , Obici, Laura , Brambatti, Michela

Mayo Clinic

Journal of the Peripheral Nervous System | November 8, 2022 | Volume: 27 | Issue: 4 | Pages: 228-237

10.1111/jns.12519 | PMID 36345805 Get It

AbstractTransthyretin‐mediated amyloidosis (ATTR) is a rare, under‐recognized, progressively debilitating, fatal disease caused by the aggregation and extracellular deposition of amyloid transthyretin (TTR) fibrils in multiple organs and tissues throughout the body. TTR is predominantly synthesized by the liver and normally circulates as a homotetramer, while misfolded monomers aggregate to form amyloid fibrils. One strategy to treat ATTR amyloidosis is to reduce the amount of TTR produced by the liver using drugs that directly target the TTR mRNA or gene. This narrative review focuses on how TTR gene silencing tools act to reduce TTR production, describing strategies for improved targeted delivery of these agents to hepatocytes where TTR is preferentially expressed. Antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs), termed RNA silencers, cause selective degradation of TTR mRNA, while a TTR gene editing tool reduces TTR expression by introducing nonsense mutations into the TTR gene. Two strategies to facilitate tissue‐specific delivery of these nucleic acid‐based drugs employ endogenous receptors expressed by hepatocytes. Lipid nanoparticles (LNPs) that recruit apolipoprotein E support low‐density lipoprotein receptor‐mediated uptake of unconjugated siRNA and are now used for CRISPR gene editing tools. Additionally, conjugating N‐acetylgalactosamine (GalNAc) moieties to ASOs or siRNAs facilitates receptor‐mediated uptake by the asialoglycoprotein receptor. In summary, ATTR is a progressive disease with various clinical manifestations due to TTR aggregation, deposition, and amyloid formation. Receptor‐targeted ligands (eg, GalNAc) and nanoparticle encapsulation (eg, LNPs) are technologies to deliver ASOs, siRNAs, and gene editing tools to hepatocytes, the primary location of TTR synthesis.
In Reply: Spine Surgery Under Spinal vs General Anesthesia: Prospective Analysis of Quality of Life, Fatigue, and Cognition
Gruenbaum, Shaun E. , Quiñones‐Hinojosa, Alfredo , Abode-Iyamah, Kingsley O., Biase, Gaetano De , Abode-Iyamah, Kingsley

Mayo Clinic

Neurosurgery | November 8, 2022 | Volume: 92 | Issue: 1 | Pages: e10-e10

10.1227/neu.0000000000002218 | PMID 36346234 Get It

Characteristics and Outcomes of Sepsis Presenting in Inpatient Pediatric Settings
Schafer, Melissa , Souza, Heidi G. De , Paul, Raina, Riggs, Ruth , Richardson, Troy , Conlon, Patricia M. , Duffy, Susan , Foster, Lauren Z. , Gunderson, Julie , Hall, David E. , Hatcher, Laura, Hess, Lauren M. , Kirkpatrick, Lauren, Kunar, Jillian, Lockwood, Justin , Lowerre, Tracy, McFadden, Vanessa , Raghavan, Anita, Rizzi, Jennifer, Stephen, Rebecca, Stokes, Stacey, Workman, Jennifer K. , Auletta, Jeffery J. , Frizzola, Meg , Priebe, Gregory P. , Conlon, Patricia, Hall, David , Auletta, Jeffery J , Gunderson, Julie, Lockwood, Justin M. , Raghavan, Anita, Kandil, Sarah

Mayo Clinic

Hospital Pediatrics | November 8, 2022 | Volume: 12 | Issue: 12 | Pages: 1048-1059

10.1542/hpeds.2022-006592 | PMID 36345706 Get It

OBJECTIVE The pediatric sepsis literature lacks studies examining the inpatient setting, yet sepsis remains a leading cause of death in children’s hospitals. More information is needed about sepsis arising in patients already hospitalized to improve morbidity and mortality outcomes. This study describes the clinical characteristics, process measures, and outcomes of inpatient sepsis cases compared with emergency department (ED) sepsis cases within the Improving Pediatric Sepsis Outcomes data registry from 46 hospitals that care for children. METHODS This retrospective cohort study included Improving Pediatric Sepsis Outcomes sepsis cases from January 2017 to December 2019 with onset in inpatient or ED. We used descriptive statistics to compare inpatient and ED sepsis metrics and describe inpatient sepsis outcomes. RESULTS The cohort included 26 855 cases; 8.4% were inpatient and 91.6% were ED. Inpatient cases had higher sepsis-attributable mortality (2.0% vs 1.4%, P = .025), longer length of stay after sepsis recognition (9 vs 5 days, P <.001), more intensive care admissions (57.6% vs 54.1%, P = .002), and greater average vasopressor use (18.0% vs 13.6%, P <.001) compared with ED. In the inpatient cohort, >40% of cases had a time from arrival to recognition within 12 hours. In 21% of cases, this time was >96 hours. Improved adherence to sepsis treatment bundles over time was associated with improved 30-day sepsis-attributable mortality for inpatients with sepsis. CONCLUSIONS Inpatient sepsis cases had longer lengths of stay, more need for intensive care, and higher vasopressor use. Sepsis-attributable mortality was significantly higher in inpatient cases compared with ED cases and improved with improved sepsis bundle adherence.